Carol Hudon

Dr. Carol Hudon

orcid

Research Focus & Metrics

Academic Career Length

25Years (2002-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 April 2012 in SLEEP
Verified
Journal Article
Closed access
OPOlivier Potvin
Olivier Potvin
DLDominique Lorrain
Dominique Lorrain
HFHélène Forget
Hélène Forget
MDMicheline Dubé
Micheline Dubé
SGSébastien Grenier
Sébastien Grenier
CHCarol Hudon
Carol Hudon
S and full research articles published in SLEEP, the official journal of the APSS. Sleep and sleep disorder scientific findings.

1 August 2009 in International Psychogeriatrics
Verified
Journal Article
Open access
SBSimon Beaulieu-Bonneau
Simon Beaulieu-Bonneau
CHCarol Hudon
Carol Hudon
Normal aging and dementia are characterized by increased prevalence of sleep disorders and alterations of both sleep continuity and architecture. However, little is still known about the nature of sleep in mild cognitive impairment (MCI), which is presumably situated on the continuum from healthy aging to dementia. This unsystematic review summarizes the current literature on the prevalence and severity of sleep disturbances in MCI. Eighteen studies addressing sleep/night-time disturbances among other neuropsychiatric symptoms in individuals with MCI were identified through a search of databases and an examination of reference lists of selected papers. Fifteen of those studies reported data on prevalence or severity of sleep/night-time disturbances. Results indicated that 14-59% of patients with MCI had sleep disturbances. These disturbances were often identified as one of the four most prevalent neuropsychiatric symptoms of MCI and were considered as clinically significant in some studies. In addition, there was some evidence that the prevalence of sleep disturbances in MCI is intermediate between that of normal aging and dementia. Longitudinal data suggest that sleep problems are associated with both incident MCI and dementia. These findings support the hypothesis that sleep disturbances are one of the core non-cognitive symptoms of MCI. It remains to be known whether sleep problems could help to identify those individuals with MCI who will eventually develop dementia. Studies characterizing sleep more systematically are needed to verify this proposition and to clarify the associations between sleep disturbances and other neuropsychiatric symptoms of MCI.

13 September 2016 in Archives of Clinical Neuropsychology
Verified
Journal Article
Closed access
PDF file
ELEddy Larouche
Eddy Larouche
MTMarie-Pier Tremblay
Marie-Pier Tremblay
OPOlivier Potvin
Olivier Potvin
SLSophie Laforest
Sophie Laforest
DBDavid Bergeron
David Bergeron
CHCarol Hudon
Carol Hudon
Objective Given that aging is associated with higher risk of cognitive decline and dementia, improving early detection of cognitive impairment has become a research and clinical priority. The Montreal Cognitive Assessment (MoCA) is a screening instrument used to assess different aspects of cognition. Despite its widespread use, norms adjusted to the sociodemographics of Quebec-French people are not yet available. Such norms are however important because performance on neuropsychological tests varies according to sociodemographic variables including age, sex, and education. As such, the present study aimed to establish normative data for the MoCA in middle-aged and elderly Quebec-French population. Method For that purpose, 1,019 community-dwelling older adults aged between 41 and 98 were recruited. Participants from 12 recruiting sites completed the MoCA. Regression-based normative data were produced and cross-validated with a validation sample (n = 200). Results Regression analyses indicated that older age, lower education level, and male sex were associated with poorer MoCA scores. The best predictive model included age (p < .001), education (p < .001), sex (p < .001), and a quadratic term for education (education X education; p < .001). This model explained a significant amount of variance of the MoCA score (p < .001, R2 = 0.26). A regression equation to calculate Z scores is presented. Conclusions This study provides normative data for the MoCA test in the middle-aged and elderly French-Quebec people. These data will facilitate more accurate detection and follow-up of the risk of cognitive impairment in this population, taking into account culture, age, education, and sex.

19 July 2018 in The Journals of Gerontology, Series A: Biological Sciences and Medical Sciences
Verified
Journal Article
Closed access
PDF file
JBJulien Bensalem
Julien Bensalem
SDStéphanie Dudonné
Stéphanie Dudonné
NENicole Etchamendy
Nicole Etchamendy
HPHermine Pellay
Hermine Pellay
CACamille Amadieu
Camille Amadieu
VPVéronique Pallet
Véronique Pallet
Polyphenols are promising nutritional bioactives exhibiting beneficial effect on age-related cognitive decline. The present study evaluated the effect of a polyphenol-rich extract from grape and blueberry (PEGB) on memory of healthy elderly subjects (60–70 years-old). A bicentric, randomized, double-blind, placebo-controlled trial was conducted with 215 volunteers receiving 600 mg/day of PEGB (containing 258 mg flavonoids) or a placebo for 6 months. The primary outcome was the CANTAB Paired Associate Learning (PAL), a visuospatial learning and episodic memory test. Secondary outcomes included verbal episodic and recognition memory (VRM) and working memory (SSP). There was no significant effect of PEGB on the PAL on the whole cohort. Yet, PEGB supplementation improved VRM free recall. Stratifying the cohort in quartiles based on PAL at baseline revealed a subgroup with advanced cognitive decline (decliners) who responded positively to the PEGB. In this group, PEGB consumption was also associated with a better VRM delayed recognition. In addition to a lower polyphenol consumption, the urine metabolomic profile of decliners revealed that they excreted more metabolites. Urinary concentrations of specific flavan-3-ols metabolites were associated, at the end of the intervention, with the memory improvements. Our study demonstrates that PEGB improves age-related episodic memory decline in individuals with the highest cognitive impairments.

7 March 2017 in Neuropsychology Review
Verified
Journal Article
Closed access
PDF file
TGthe Subjective Cognitive Decline Initiative (SCD-I) Working Group
the Subjective Cognitive Decline Initiative (SCD-I) Working Group
CSColette M. Smart
Colette M. Smart
JKJustin E. Karr
Justin E. Karr
CACorson N. Areshenkoff
Corson N. Areshenkoff
LRLaura A. Rabin
Laura A. Rabin
LWLinda Wesselman
Linda Wesselman

1 April 2011 in The American Journal of Geriatric Psychiatry
Verified
Journal Article
Closed access
SGSébastien Grenier
Sébastien Grenier
MPMichel Préville
Michel Préville
RBRichard Boyer
Richard Boyer
KOKieron O’connor
Kieron O’connor
SBSarah-Gabrielle Béland
Sarah-Gabrielle Béland
JBJoëlle Brassard
Joëlle Brassard